1. Home
  2. ABCL vs AVDL Comparison

ABCL vs AVDL Comparison

Compare ABCL & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • AVDL
  • Stock Information
  • Founded
  • ABCL 2012
  • AVDL 2015
  • Country
  • ABCL Canada
  • AVDL Ireland
  • Employees
  • ABCL N/A
  • AVDL N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABCL Health Care
  • AVDL Health Care
  • Exchange
  • ABCL Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • ABCL 772.9M
  • AVDL 784.6M
  • IPO Year
  • ABCL 2020
  • AVDL 1996
  • Fundamental
  • Price
  • ABCL $2.02
  • AVDL $9.11
  • Analyst Decision
  • ABCL Strong Buy
  • AVDL Strong Buy
  • Analyst Count
  • ABCL 4
  • AVDL 6
  • Target Price
  • ABCL $8.33
  • AVDL $18.17
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • AVDL 1.3M
  • Earning Date
  • ABCL 05-08-2025
  • AVDL 05-07-2025
  • Dividend Yield
  • ABCL N/A
  • AVDL N/A
  • EPS Growth
  • ABCL N/A
  • AVDL N/A
  • EPS
  • ABCL N/A
  • AVDL N/A
  • Revenue
  • ABCL $23,114,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • ABCL N/A
  • AVDL $55.11
  • Revenue Next Year
  • ABCL $36.62
  • AVDL $30.13
  • P/E Ratio
  • ABCL N/A
  • AVDL N/A
  • Revenue Growth
  • ABCL N/A
  • AVDL 252.64
  • 52 Week Low
  • ABCL $1.89
  • AVDL $6.38
  • 52 Week High
  • ABCL $4.20
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 40.97
  • AVDL 53.96
  • Support Level
  • ABCL $1.97
  • AVDL $8.77
  • Resistance Level
  • ABCL $2.08
  • AVDL $9.31
  • Average True Range (ATR)
  • ABCL 0.10
  • AVDL 0.41
  • MACD
  • ABCL 0.01
  • AVDL -0.04
  • Stochastic Oscillator
  • ABCL 29.63
  • AVDL 53.60

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: